269 related articles for article (PubMed ID: 30220322)
1. Protective effects of metformin, statins and anti-inflammatory drugs on head and neck cancer: A systematic review.
Saka Herrán C; Jané-Salas E; Estrugo Devesa A; López-López J
Oral Oncol; 2018 Oct; 85():68-81. PubMed ID: 30220322
[TBL] [Abstract][Full Text] [Related]
2. Head and neck cancer and non-steroidal anti-inflammatory drugs: Systematic review and meta-analysis.
Saka-Herrán C; Jané-Salas E; Estrugo-Devesa A; López-López J
Head Neck; 2021 May; 43(5):1664-1682. PubMed ID: 33682986
[TBL] [Abstract][Full Text] [Related]
3. Non-steroidal anti-inflammatory drug and aspirin use and the risk of head and neck cancer: a systematic review.
Wilson JC; Anderson LA; Murray LJ; Hughes CM
Cancer Causes Control; 2011 May; 22(5):803-10. PubMed ID: 21409528
[TBL] [Abstract][Full Text] [Related]
4. Common medications and survival in women with ovarian cancer: A systematic review and meta-analysis.
Majidi A; Na R; Dixon-Suen S; Jordan SJ; Webb PM
Gynecol Oncol; 2020 Jun; 157(3):678-685. PubMed ID: 32317171
[TBL] [Abstract][Full Text] [Related]
5. Association of nonsteroidal anti-inflammatory drugs and aspirin use and the risk of head and neck cancers: a meta-analysis of observational studies.
Tang L; Hu H; Liu H; Jian C; Wang H; Huang J
Oncotarget; 2016 Oct; 7(40):65196-65207. PubMed ID: 27533449
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular/anti-inflammatory drugs repurposed for treating or preventing cancer: A systematic review and meta-analysis of randomized trials.
Benjamin DJ; Haslam A; Prasad V
Cancer Med; 2024 Mar; 13(5):e7049. PubMed ID: 38491813
[TBL] [Abstract][Full Text] [Related]
7. The effect of concomitant use of statins, NSAIDs, low-dose aspirin, metformin and beta-blockers on outcomes in patients receiving immune checkpoint inhibitors: a systematic review and meta-analysis.
Zhang Y; Chen H; Chen S; Li Z; Chen J; Li W
Oncoimmunology; 2021; 10(1):1957605. PubMed ID: 34377596
[TBL] [Abstract][Full Text] [Related]
8. Non-steroidal anti-inflammatory drugs and the risk of head and neck cancer: A case-control analysis.
Becker C; Wilson JC; Jick SS; Meier CR
Int J Cancer; 2015 Nov; 137(10):2424-31. PubMed ID: 25974157
[TBL] [Abstract][Full Text] [Related]
9. Combination regimen with statins and NSAIDs: a promising strategy for cancer chemoprevention.
Xiao H; Yang CS
Int J Cancer; 2008 Sep; 123(5):983-90. PubMed ID: 18548583
[TBL] [Abstract][Full Text] [Related]
10. Survival impact and toxicity of metformin in head and neck cancer: An analysis of the SEER-Medicare dataset.
Stokes WA; Eguchi M; Amini A; Hararah MK; Ding D; McDermott JD; Bradley CJ; Karam SD
Oral Oncol; 2018 Sep; 84():12-19. PubMed ID: 30115470
[TBL] [Abstract][Full Text] [Related]
11. Aspirin, Statins, Non-aspirin NSAIDs, Metformin, and the Risk of Biliary Cancer: A Swedish Population-Based Cohort Study.
Marcano-Bonilla L; Schleck CD; Harmsen WS; Sadr-Azodi O; Borad MJ; Patel T; Petersen GM; Therneau TM; Roberts LR; Brusselaers N
Cancer Epidemiol Biomarkers Prev; 2022 Apr; 31(4):804-810. PubMed ID: 35086822
[TBL] [Abstract][Full Text] [Related]
12. Metformin and the risk of head and neck cancer: a case-control analysis.
Becker C; Jick SS; Meier CR; Bodmer M
Diabetes Obes Metab; 2014 Nov; 16(11):1148-54. PubMed ID: 25041125
[TBL] [Abstract][Full Text] [Related]
13. Diabetes mellitus, metformin and head and neck cancer.
Figueiredo RA; Weiderpass E; Tajara EH; Ström P; Carvalho AL; de Carvalho MB; Kanda JL; Moyses RA; Wünsch-Filho V
Oral Oncol; 2016 Oct; 61():47-54. PubMed ID: 27688104
[TBL] [Abstract][Full Text] [Related]
14. The causes and effects of socio-demographic exclusions from clinical trials.
Bartlett C; Doyal L; Ebrahim S; Davey P; Bachmann M; Egger M; Dieppe P
Health Technol Assess; 2005 Oct; 9(38):iii-iv, ix-x, 1-152. PubMed ID: 16181564
[TBL] [Abstract][Full Text] [Related]
15. Drugs with potential chemopreventive properties in relation to epithelial ovarian cancer--a nationwide case-control study.
Baandrup L
Dan Med J; 2015 Jul; 62(7):. PubMed ID: 26183052
[TBL] [Abstract][Full Text] [Related]
16. Association between metformin therapy and incidence, recurrence and mortality of prostate cancer: evidence from a meta-analysis.
Deng D; Yang Y; Tang X; Skrip L; Qiu J; Wang Y; Zhang F
Diabetes Metab Res Rev; 2015 Sep; 31(6):595-602. PubMed ID: 25708557
[TBL] [Abstract][Full Text] [Related]
17. Metformin and sulfonylureas in relation to cancer risk in type II diabetes patients: a meta-analysis using primary data of published studies.
Thakkar B; Aronis KN; Vamvini MT; Shields K; Mantzoros CS
Metabolism; 2013 Jul; 62(7):922-34. PubMed ID: 23419783
[TBL] [Abstract][Full Text] [Related]
18. Effects of metformin on head and neck cancer: a systematic review.
Rêgo DF; Pavan LM; Elias ST; De Luca Canto G; Guerra EN
Oral Oncol; 2015 May; 51(5):416-22. PubMed ID: 25636350
[TBL] [Abstract][Full Text] [Related]
19. Effects of non-steroidal anti-inflammatory drugs on cancer sites other than the colon and rectum: a meta-analysis.
González-Pérez A; García Rodríguez LA; López-Ridaura R
BMC Cancer; 2003 Oct; 3():28. PubMed ID: 14588079
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
